A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

CD4 Antigens

Trial Locations (6)

60614

Children's Memorial Med Ctr, Chicago

94143

Northern California Pediatric AIDS Treatment Ctr / UCSF, San Francisco

277103499

Duke Univ Med Ctr, Durham

606143394

Chicago Children's Memorial Hosp, Chicago

943054149

Stanford Univ School of Medicine / Pediatrics, Stanford

071072198

Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl, Newark

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH